The first stop for professional medicines advice

Procurement of unlicensed medicines and other services managed by CMU

Published
Topics: Policy, Commissioning and ManagerialTrusts

Purchasing of medicines is a complex process with many factors to consider

This article forms part of a series
  1. An overview of Procurement of Medicines and Pharmaceutical Products and Services for NHS hospitals
    1. Procurement Structure
    2. Arrangements for Procurement of Medicines and Pharmaceutical Products and Services
    3. Procurement of licensed medicines
    4. "Tranche" branded medicines in a competitive market
    5. Procurement of unlicensed medicines and other services managed by CMU
    6. Net Zero and Social Value requirements in NHSE medicines tenders
    7. Pricing and contract coverage
    8. Collaborative Purchasing Organisations
    9. Procurement systems in Scotland, Wales and Northern Ireland

Homecare Team

This is a CMU team, which is responsible for the procurement of several key services.

Blood clotting factors

The blood clotting factors homecare service is procured under a 2- year framework (with extension options) for England, Wales and Northern Ireland.

Pulmonary hypertension

The pulmonary hypertension homecare service is procured under a 2 year framework (with extension options) for England.

Enzyme replacement therapy

The enzyme replacement therapy homecare service is procured under a 2 year framework (with extension options) for England and Scotland.

Home Parenteral Nutrition (PN)

Home PN is procured under a 2 year framework (with extension options) for England.

Branded Team

The CMU team responsible for branded medicines also manages the following service.

Dose banded chemotherapy

Dose banded chemotherapy is procured under a 2 year framework (with extension options) for North of England, London, East of England and South East Coast.